CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
FFDM Plus DBT +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02685566
NCT02685566N/ACompleted

A Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Adequacy of the Fujifilm Full Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) Reader Training Program - A Pilot Study

Fujifilm Medical Systems USA, Inc.·interventional·Posted Feb 18, 2016·Updated Sep 21, 2023

In Brief

A clinical study evaluating FFDM Plus DBT and FFDM for Breast Cancer. Completed, enrolled 100 participants across 5 sites.

Detailed Summary

The purpose of this pilot is to assess the adequacy of the Fujifilm DBT Reader Study Training program to ensure that Readers participating in the Fujifilm DBT pivotal trial are properly trained in the reading and interpretation of FFDM and DBT images.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 18, 2016
Enrollment StartAug 1, 2015
Primary CompletionAug 1, 2015
Study CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 10.4 years ago

Interventions

FFDM Plus DBTdevice

FujiFilm Aspire Cristalle System

FFDMdevice

FujiFilm Aspire Cristalle System